Biotech Stock Roundup: VRTX/CRSP Gene Therapy Label Expansion, ALLK Falls on Update
https://www.zacks.com/stock/news/2212227/biotech-stock-roundup-vrtx-crsp-gene-therapy-label-expansion-allk-falls-on-update?cid=CS-ZC-FT-analyst_blog|stock_roundup-2212227
Jan 18, 2024 - Vertex (VRTX), CRSP and Allakos are in the spotlight on regulatory and pipeline updates.
0
Here's Why Allakos Inc. (ALLK) is Poised for a Turnaround After Losing -61.36% in 4 Weeks
https://www.zacks.com/stock/news/2212071/here-s-why-allakos-inc-allk-is-poised-for-a-turnaround-after-losing-61-36-in-4-weeks?cid=CS-ZC-FT-tale_of_the_tape|rsi-2212071
Jan 18, 2024 - The heavy selling pressure might have exhausted for Allakos Inc. (ALLK) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
0
Pages: 1
Page 1